Researchers at the University of Illinois at Chicago have found that genetic differences might predict the patient’s response to ADD medication, namely stimulant medication. A study found that children with a variant form of a dopamine transporter gene — a variant known to be associated with ADHD — responded poorly to one of the most

Found an online press release for a teleconference with Marc Berthiaume, Director of the Marketed Pharmaceuticals Division of the Marketed Health Products Directorate of Health Canada on Adderall XR which has recently been put back on the market after suspending it in February 2005, in a controversial move. I.e., it was supposedly pulled of the